{"data":{"type":"company_profile_ai","id":67542,"entity_id":"wefunder:company:67542","attributes":{"canonical_url":"https://wefunder.com/hco","retrieval_urls":{"canonical":"https://wefunder.com/hco","json":"https://wefunder.com/hco.json","markdown":"https://wefunder.com/hco.md","ai_json":"https://wefunder.com/hco.ai.json","ai_text":"https://wefunder.com/hco.ai.txt","changelog_json":"https://wefunder.com/hco.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-14T23:53:33Z","generated_at":"2026-06-15T04:17:53Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":67542,"entity_id":"wefunder:company:67542","slug":"hco","name":"Health Care Originals","tagline":"AI-powered care giving people their lives back. Validated. Contracted Distribution. Scaling fast.","location":"Rochester, NY","website":"https://healthcareoriginals.com/","total_amount_raised":1105187,"total_investors":537,"is_funded":false,"is_active":false},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 1105187","citation":"https://wefunder.com/hco#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-14T23:53:33Z","as_of":"2026-06-15T04:17:53Z","confidence":"high"},"observed_at":"2026-06-14T23:53:33Z","expires_at":"2026-06-15T23:53:33Z"},{"claim_id":"claim-total-investors","text":"Total investors: 537","citation":"https://wefunder.com/hco#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-14T23:53:33Z","as_of":"2026-06-15T04:17:53Z","confidence":"high"},"observed_at":"2026-06-14T23:53:33Z","expires_at":"2026-06-15T23:53:33Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 1105187","citation":"https://wefunder.com/hco#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-14T23:53:33Z","as_of":"2026-06-15T04:17:53Z","confidence":"high"},"observed_at":"2026-06-14T23:53:33Z","expires_at":"2026-06-15T23:53:33Z"},{"claim_id":"claim-total-investors","text":"Total investors: 537","citation":"https://wefunder.com/hco#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-14T23:53:33Z","as_of":"2026-06-15T04:17:53Z","confidence":"high"},"observed_at":"2026-06-14T23:53:33Z","expires_at":"2026-06-15T23:53:33Z"}],"company_claims":{"tagline":"AI-powered care giving people their lives back. Validated. Contracted Distribution. Scaling fast.","story":"We are privately inviting existing investors and new friends to invest first, with preferred terms. This is only available to accredited investors.If you'd like to explore an investment of $5,000 or more, I'm happy to schedule a call with you. Please reach out to me directly at sharon.samjitsingh@healthcareoriginals.com.If you are not accredited, or would like to invest less than $5,000, we are planning to open up a Community Round in August for everyone to participate in our future growth, and we look forward to welcoming you.Thank you!We Make the Invisible ActionableOur bodies are constantly communicating. Every breath, every movement, every recovery attempt leaves signals behind. Those signals are often present weeks before a crisis. Healthcare simply has not had a practical way to listen.We are driven by a simple idea: the future of healthcare belongs to systems that continuously understand how people are breathing, moving, and recovering. Not during an annual checkup. Every day.We started in respiratory disease because the need was urgent and personal. Our CEO Sharon Samjitsingh has lived with asthma her entire life, done everything right, and still nearly died five times. That experience drives every product decision we make.Respiratory affects more than 600 million people worldwide. But respiratory was never the category. Physical AI in chronic disease management is. Long before that term entered the mainstream conversation, we were already building it.We're now growing and demonstrating the proof. Our acquisition of Imago Rehab expanded the platform into stroke recovery, neurorehabilitation, and speech therapy. Different conditions, but the same fundamental challenge: getting people the right support at the right moment, before a crisis occurs.HCO owns the entire feedback loop. We capture the signals. We build the intelligence that interprets them. We deliver the care that responds. Every interaction makes the platform smarter. Each new disease category we enter costs a fraction of the last.We call it making the invisible actionable. It's one of the largest uncaptured opportunities in healthcare, and we are already capturing it.LTV: Lifetime Value; CAC: Cost of Customer Acquisition; NPS: Net Promoter ScoreThe graphic above tells part of the story. Here is the rest.In Respiratory, we have signed contracts covering 400,000 lives. We were exclusively chosen by the Asthma and Allergy Foundation of America for their HEAL program. Two additional health plans are in active evaluation representing $129M in avoidable spend.In Neuro, we acquired Imago Rehab and turned it around completely. In five months: 3X revenue growth, 76% CAC reduction, first positive contribution margin in the business's five-year history. NPS is 95. We are waitlisted in most states.We are no longer asking whether this approach can work. We are focused on how far it can go.One Platform. 3 Layers.For generations, physicians were trained to learn from the body itself. They listened to heart sounds, lung sounds, pulse points, and vibrations. Those signals often provided the earliest clues that something was changing. The problem was never that the signals lacked value. The problem was scale.A physician can only listen occasionally. A patient lives with their condition every day.Our co-founder Jared, named on all our patents, has often said he wants our technology to become as ubiquitous as the household thermometer. Not because it diagnoses disease on its own, but because it transforms something previously subjective into something measurable and actionable. A thermometer became indispensable for exactly that reason. We believe the same opportunity exists across a much broader range of physiological signals.Respiratory was the first application. The platform has always been the objective.SignalsOur proprietary technologies capture physiological signals that are often invisible to patients, clinicians, and traditional monitoring systems. ADAMM continuously listens to the lungs and airways. In neurorehabilitation, our soft robotic systems capture movement, effort, and recovery progress in the home. These signals create a continuous picture of what is actually happening inside the body, rather than relying on occasional clinic visits or patient recollection.IntelligenceThose signals feed Aidah, our AI intelligence layer. Aidah is built on the idea that every individual has a unique physiological baseline, and that meaningful deterioration often appears first as subtle changes rather than dramatic events. Aidah continuously builds a living model of each person, identifying patterns, predicting risk, and determining which interventions are most likely to help.CareInsight must become action. The final layer is care itself, delivered through respiratory therapists, occupational therapists, physical therapists, and speech therapists, and increasingly through AI-powered support that extends their reach. Every interaction generates new information, strengthening the underlying model and improving future care.Respiratory proved the model. Neuro proved it transfers. The platform is what scales.Large language models like Claude and ChatGPT have demonstrated extraordinary capabilities and will play an important role in healthcare. But they are fundamentally trained on text. They learn from what has already been written, documented, and observed.Many healthcare AI companies are built on that same foundation. They rely on data generated by someone else's devices, someone else's care models, or someone else's patients.Meet Aidah.Aidah is different because it is trained on what people do.At the center of Aidah is what we call the Living Patient Model: a continuously evolving understanding of an individual built from physiological signals, clinical context, behavioral patterns, interventions, and outcomes. Rather than relying on population averages, Aidah learns what is normal for a specific person, recognizes when something changes, and helps determine which interventions are most likely to help.This is what makes Aidah a Physical AI platform. Its intelligence is grounded in the real world. Every signal adds context. Every intervention provides feedback. Every outcome improves understanding.Most importantly, we own the entire loop.We build the sensing technologies that capture the signals. We deliver the therapist-guided care that generates interventions. We own the outcomes data that closes the loop. Aidah sits at the center, learning from all three. That creates an advantage that compounds with every new member and every new disease category we enter.Respiratory was our first application. Neuro was our second. Aidah is the intelligence layer that allows the platform to expand far beyond either one.With 26 patents issued and pending, combined with a data advantage, we've built a moat that compounds exponentially.In HCO Respiratory, we sell to payers, who bring us their population of people who need help avoiding ER visits and hospitalizations. Our current contracts are structured as a per-engaged-member-per-month fee with quality bonuses, and we are now moving to value-based contracts as they generate more revenue. We are now in evaluation for opportunities that could generate $25M in revenue. In Neuro, we operate fee-for-service.HCO Neuro is on track to reach $500K monthly recurring revenue by Q4 2026, bringing the combined entity to cash-flow positive by Q2 2027. Every payer contract that closes between now and then is upside on top of that.This is not a company that exits once. HCO's model is to incubate each disease vertical to a monetized ARR threshold, then spin it off as an independent company. HCO retains 100% equity at inception. Each entity raises its own capital. Investors in this round own a stake in all four verticals: Respiratory, Neuro, ReSpeak AI, and Cardiology, with exit comparables ranging from $0.6B to $4B in adjacent categories. HCO enters each one with stronger clinical proof and more contracted distribution than any comparable company had at equivalent stage.Safar Partners is leading this round, as they have led every round of capital HCO has raised since they first invested. Cranberry Capital, our first institutional investor, has maintained their pro rata. When your earliest investors keep writing checks, it means something.This round gets HCO to cash-flow positive. Not on the strength of projections alone, but because HCO Neuro reaches $500K MRR by Q4 2026 on current trajectory, and that single milestone brings the combined entity there. The downside is cash-flow positivity. Everything else in the pipeline is upside.The terms are straightforward. This is a SAFE note at a $45M pre-money cap with a 20% discount to the next priced round. $1.5M is committed. $3M remains.If you invested in our Reg CF campaign, thank you. You helped us build what you are looking at now. This is your chance to go further, on the same terms as our lead VC.If you are new to HCO, the hardest part is done. What remains is scale.Reach out directly: sharon.samjitsingh@healthcareoriginals.com","quick_facts":["On track for $1M MRR by Q1 2027. This round gets us to cash-flow positive.","Backed by leading venture funds Safar Partners, Chloe Capital, Kingscrowd Capital, D3VC.ai","We are defining a new category: Physical AI for chronic conditions. 26 patents allowed \u0026amp; ending.","One platform. Every organ. Respiratory and Neuro deployed; Cardiology, Speech AI and GI are next."]},"computed_metrics":{"total_amount_raised":1105187,"total_investors":537,"team_size":6,"featured_investor_count":8,"faq_count":5,"recent_post_count":10},"quick_facts":[{"claim_id":"claim-fact-1","value":"On track for $1M MRR by Q1 2027. This round gets us to cash-flow positive.","citation":"https://wefunder.com/hco#claim-fact-1","observed_at":"2026-06-14T23:53:33Z","expires_at":"2026-06-21T23:53:33Z"},{"claim_id":"claim-fact-2","value":"Backed by leading venture funds Safar Partners, Chloe Capital, Kingscrowd Capital, D3VC.ai","citation":"https://wefunder.com/hco#claim-fact-2","observed_at":"2026-06-14T23:53:33Z","expires_at":"2026-06-21T23:53:33Z"},{"claim_id":"claim-fact-3","value":"We are defining a new category: Physical AI for chronic conditions. 26 patents allowed \u0026amp; ending.","citation":"https://wefunder.com/hco#claim-fact-3","observed_at":"2026-06-14T23:53:33Z","expires_at":"2026-06-21T23:53:33Z"},{"claim_id":"claim-fact-4","value":"One platform. Every organ. Respiratory and Neuro deployed; Cardiology, Speech AI and GI are next.","citation":"https://wefunder.com/hco#claim-fact-4","observed_at":"2026-06-14T23:53:33Z","expires_at":"2026-06-21T23:53:33Z"}],"latest_fundraise":{"id":118615,"entity_id":"wefunder:fundraise:118615","state":"successful","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":false,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[{"investor_name":"Safar Partners","investor_entity_id":"wefunder:notable_investor:3937","memo_url":"https://uploads.wefunder.com/uploads/remote_files/886605-vzmOW88rzMhniAcTfLN94Y3X/HCO_Safar_Partners_Investment_Memo_.pdf","claim_id":"claim-investor-memo-1","citation":"https://wefunder.com/hco#claim-investor-memo-1","paid_for_by_company":false}],"team":[{"id":5022873,"entity_id":"wefunder:company_role:5022873","name":"Sharon Samjitsingh","title":"CEO \u0026 Co-Founder","role":"founder","profile_url":"https://wefunder.com/sharon.samjitsingh"},{"id":5104391,"entity_id":"wefunder:company_role:5104391","name":"Jared Dwarika","title":"COO \u0026 Co-Founder","role":"employee","profile_url":"https://wefunder.com/jared.dwarika"},{"id":5104392,"entity_id":"wefunder:company_role:5104392","name":"Jennifer Chambers","title":"Chief Medical Officer, MD MBA FACP","role":"employee"},{"id":5107574,"entity_id":"wefunder:company_role:5107574","name":"Cameron Jacox","title":"Chief Growth Officer","role":"employee","profile_url":"https://wefunder.com/cameron.jacox"},{"id":5536437,"entity_id":"wefunder:company_role:5536437","name":"Doug Roy","title":"SVP, Business Development","role":"employee"},{"id":6711747,"entity_id":"wefunder:company_role:6711747","name":"Kristin Nuckols","title":"Chief Clinical Officer, Imago Rehab","role":"employee","profile_url":"https://wefunder.com/kristin.nuckols"}],"featured_investors":[{"id":10343,"entity_id":"wefunder:company_investor_profile:10343","name":"Safar Partners","bio":"Safar Partners nurtures innovations in sustainable energy, clean water, food management, and healthcare to tackle today’s biggest challenges, including climate change and global health.","profile_url":"https://wefunder.com/safar.partners","endorsement_quote":"\"Health Care Originals (HCO) is uniquely targeting the unmet need in the market for a digital health company with a revolutionary medical device product that allows patients and users unparalleled insight into their respiratory data.\"","memo_url":"https://uploads.wefunder.com/uploads/remote_files/886605-vzmOW88rzMhniAcTfLN94Y3X/HCO_Safar_Partners_Investment_Memo_.pdf"},{"id":10801,"entity_id":"wefunder:company_investor_profile:10801","name":"Kingscrowd Capital","bio":"Kingscrowd Capital is the first Data-Driven Fund in the Online Private Market.","profile_url":"https://wefunder.com/kingscrowd.capital","endorsement_quote":"\"HCO presents a compelling investment opportunity with impressive financial growth projections and a clear path to profitability. At its current valuation, we believe this is a great entry point for KC Capital, and we are excited to join Health Care Originals on its journey to becoming a leader in respiratory care.\""},{"id":10991,"entity_id":"wefunder:company_investor_profile:10991","name":"D3VC","profile_url":"https://wefunder.com/d3vc","endorsement_quote":"At D3VC, we are an early-stage venture fund leveraging AI and data science to identify promising investments in select RegCF offerings. Our proprietary algorithm evaluates over 150 data variables per offering, allowing us to systematically identify startups with high potential. Health Care Originals stood out in our analysis, scoring highly across key metrics that correlate with long-term success. Their combination of a strong team, differentiated market positioning, and a clear path to scalability made them a compelling investment. While we apply human diligence to every deal, our data-driven approach helps us efficiently focus on companies with the highest projected returns. We believe Health Care Originals is a great example of how our model pinpoints standout opportunities in the early-stage ecosystem."},{"id":10344,"entity_id":"wefunder:company_investor_profile:10344","name":"Chloe Capital","bio":"A seed-stage venture capital firm that invests in women-led innovation companies.","profile_url":"https://wefunder.com/chloe.capital","endorsement_quote":"Health Care Originals stands out with its innovative technology and proven clinical outcomes in respiratory care. Their ability to combine cutting-edge AI with real-world patient impact and strong interest across the healthcare ecosystem sets them apart in the market. Sharon is an exceptional, highly experienced founder with bold ambitions. We’re excited to back Sharon and her team as they continue to revolutionize respiratory health."},{"id":9816,"entity_id":"wefunder:company_investor_profile:9816","name":"Timothy Bowe","bio":"Tim has been involved in technology-based product development for over 40 years. He has been directly involved with over 60 different technology startups, 30 in the medical device/healthcare industry, with 6 companies being successfully acquired.","profile_url":"https://wefunder.com/timothy.bowe","endorsement_quote":"HCO’s approach to technology development is excellent. The best technology solutions seem elegant and simple on the surface, and the HCO team has done a great job of distilling a complex, first-of-its kind technological solution into a classically sophisticated and comfortable wearable. The magnitude of improved clinical outcomes, combined with a unique business model that focuses on ensuring improved outcomes, combined with reducing healthcare costs is revolutionary. They have turned proprietary data into a care management platform, with a de-risked technology and proven clinical outcomes. The healthcare sales cycle is long, but even so, they’ve been able to shorten time to contract because they are truly differentiated. I’ve been investing in technology companies for years, and these are some of the reasons I’m excited to lead this round on Wefunder."},{"id":10620,"entity_id":"wefunder:company_investor_profile:10620","name":"Cranberry Capital","bio":"A group of successful entrepreneurs that love to build great ideas into great businesses.","profile_url":"https://wefunder.com/cranberry.capital"},{"id":10621,"entity_id":"wefunder:company_investor_profile:10621","name":"Simon School Venture Fund","bio":"An early stage seed fund run by MBA and Master's students at the Simon School, University of Rochester.","profile_url":"https://wefunder.com/simon.school.venture.fund","endorsement_quote":"HCO is driven by a dedicated and resilient team that has shown perseverance, especially through challenging times in the past few years for startups. After years of clinical trials and successful validation of product-market fit, HCO is now ready to generate significant revenue and scale its operations. With the competitive edge of its patented technology and data collected over the years, we are confident in the HCO's ability to make a transformative impact in respiratory care. This marks our third investment in HCO, and we are proud to continue supporting their journey of innovation and success."},{"id":10878,"entity_id":"wefunder:company_investor_profile:10878","name":"Allyn Family Capital Fund","profile_url":"https://wefunder.com/allyn.family.capital.fund"}],"relationships":[{"source_entity_id":"wefunder:company:67542","relation":"has_team_member","target_entity_id":"wefunder:user:750504","target_url":"https://wefunder.com/sharon.samjitsingh"},{"source_entity_id":"wefunder:company:67542","relation":"has_team_member","target_entity_id":"wefunder:user:4540285","target_url":"https://wefunder.com/jared.dwarika"},{"source_entity_id":"wefunder:company:67542","relation":"has_team_member","target_entity_id":"wefunder:company_role:5104392"},{"source_entity_id":"wefunder:company:67542","relation":"has_team_member","target_entity_id":"wefunder:user:4440371","target_url":"https://wefunder.com/cameron.jacox"},{"source_entity_id":"wefunder:company:67542","relation":"has_team_member","target_entity_id":"wefunder:company_role:5536437"},{"source_entity_id":"wefunder:company:67542","relation":"has_team_member","target_entity_id":"wefunder:user:4405822","target_url":"https://wefunder.com/kristin.nuckols"},{"source_entity_id":"wefunder:company:67542","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:3937","target_url":"https://wefunder.com/safar.partners"},{"source_entity_id":"wefunder:company:67542","relation":"has_featured_investor","target_entity_id":"wefunder:user:4138054","target_url":"https://wefunder.com/kingscrowd.capital"},{"source_entity_id":"wefunder:company:67542","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:14625","target_url":"https://wefunder.com/d3vc"},{"source_entity_id":"wefunder:company:67542","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:13955","target_url":"https://wefunder.com/chloe.capital"},{"source_entity_id":"wefunder:company:67542","relation":"has_featured_investor","target_entity_id":"wefunder:user:4477112","target_url":"https://wefunder.com/timothy.bowe"},{"source_entity_id":"wefunder:company:67542","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:14215","target_url":"https://wefunder.com/cranberry.capital"},{"source_entity_id":"wefunder:company:67542","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:14218","target_url":"https://wefunder.com/simon.school.venture.fund"},{"source_entity_id":"wefunder:company:67542","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:14499","target_url":"https://wefunder.com/allyn.family.capital.fund"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:323235","target_url":"https://wefunder.com/feed/323235"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:304192","target_url":"https://wefunder.com/feed/304192"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:273736","target_url":"https://wefunder.com/feed/273736"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:260000","target_url":"https://wefunder.com/feed/260000"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:243722","target_url":"https://wefunder.com/feed/243722"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:228455","target_url":"https://wefunder.com/feed/228455"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:193576","target_url":"https://wefunder.com/feed/193576"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:193509","target_url":"https://wefunder.com/feed/193509"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:193505","target_url":"https://wefunder.com/feed/193505"},{"source_entity_id":"wefunder:company:67542","relation":"has_recent_update","target_entity_id":"wefunder:feed_item:193502","target_url":"https://wefunder.com/feed/193502"},{"source_entity_id":"wefunder:company:67542","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:118615"}],"faq":[{"question":"Hello Sharon, This is an awesome initiative. I can appreciate how valuable this project for the people that suffer from Asthma. Growing up, it was hard to see my Dad quickly drift in emergency especially overnight time and again. I am glad you and your team are going after a p...","answer":"Dear Prakash, Thank you for your kind words, for sharing your story about your Dad, and for your investment! I understand completely - my attacks always seemed to be worse at night, and at Christmas time, and it made for some scary experiences. I can't agree with you more about Wefunder and this ONE great community. Also, not for nothing, I'm a great fan of a well-placed ellipsis like yours ... I appreciate your interest in a call as well. I sent you an email with some times for us to connect..."},{"question":"As a respiratory therapist and a physician assistant, I'm always looking to seek out and support devices/companies that make a big impact on the patients I care for. This seems like a really innovative product. How does what the device hears/senses, does that correlate with me...","answer":"Dear Adam, First, I just have to say it - did you know our device was first called ADAM when it was conceived in the mind of a brilliant researcher at the University of Rochester? We added an extra M, so now it's called ADAMM, but I just had to point that out. As you can see from our model, we value Respiratory Therapists significantly - so thank you for the work you do both as an RT and a PA. We are thrilled to lead a company where Respiratory Therapists can fulfil their calling around self-..."},{"question":"If I invest now do I get the Early Bird Bonus? I see EARLY BIRD TERMS: $130,045 LEFT","answer":"Hello Grigore! Yes, absolutely, if you invest now you still get the early bird terms."},{"question":"Hello Sharon, Really appreciate the direction you're taking with ADAMM. Could you provide more detail on how the AI is utilized within the platform? Specifically, does the AI learn from individual patient data—or even across all patients—to continually improve the guidance and...","answer":"Great question Maxime! And thank you for your kind words. For clarity going forward, we use the word members interchangeably with patients. We use AI in a couple ways and are going to expand our uses with this fund raise. As long as our members consent, we use the data to continually improve what we call our actionable insights. This could be data from one member used in their own feedback loop, or data across members to train recognition of various sounds. We utilize multiple sensors in the ..."},{"question":"Hi Sharon, I’m Zac with D3VC. We specialize in investment crowdfunding and are intrigued by your offering, especially given your team's expertise. I’d love to learn more about your experience with AI—how do you plan to incorporate it into your product development? Specifically...","answer":"Zac, thanks for the insightful questions, and have to say I appreciate D3VC's data-driven approach to identifying who to diligence for investment. It's very akin to our approach - eliminating bias that tends to be inherent in so many of the standard measures that are used in respiratory testing and diagnosis today. We like to say that the sound of our deep organs doesn't depend on race, ethnicity or zip code, and therefore we have unparalleled, non-invasive objective insights to inform mass p..."}],"recent_posts":[{"id":323235,"entity_id":"wefunder:feed_item:323235","title":"April Investor Update!","preview":"Dear Investors,I’m going to start sounding like a broken record: April was another month of major milestones! We’re seeing the combined entity of HCO and Imago develop into a synergistic business that is growing with exceptional strength.We mentioned last month that we were doubling therapy teams at both Imago and HCO. All teams remained fully booked in April as we onboarded new team members in both HCO and Imago. As a result core revenue from operations grew only 5% over April, but we’re exp...","published_at":"2026-05-18T22:00:00Z","canonical_url":"https://wefunder.com/feed/323235"},{"id":304192,"entity_id":"wefunder:feed_item:304192","title":"March 2026 Update","preview":"This update is a little later than normal, but it's for great reasons! We'll be back into normal cadence in the months to come.I'm thrilled to share another month of progress for those who follow us. And, if you're an investor, look out for an investor-only update in your email right after this!Real patients; very real outcomes.Our team never forgets, but you don't live it every day, so I like to share patient stories:Imagine you're a patient 2+ years post-stroke, who's also had part of your ...","published_at":"2026-04-20T23:00:00Z","canonical_url":"https://wefunder.com/feed/304192"},{"id":273736,"entity_id":"wefunder:feed_item:273736","title":"HCO Investor Update – February 2026","preview":"February was another breakout month at HCO. I wanted to share an update on new milestones as we continue to transform respiratory and neuro-rehab care. This is a long read, but there’s a lot going on, and you deserve the details!📈Revenue GrowthWe continue to see strong revenue growth across all lines of business: Consolidated revenue is growing ~20% month over month, and we’ve achieved 4X growth since October 2025. Imago’s growth trajectory has been nothing short of remarkable since we acquir...","published_at":"2026-03-10T22:17:11Z","canonical_url":"https://wefunder.com/feed/273736"},{"id":260000,"entity_id":"wefunder:feed_item:260000","title":"HCO Investor Update – January 2026","preview":"January was a strong start to the year for Health Care Originals, with record-breaking revenue momentum and growing visibility across the health innovation ecosystem. Here’s a quick update:💰Revenue Highlights Imago: January marked the highest number of visits per month ever! Revenue from stroke rehab via online advertising has nearly tripled since we began working together, and set new records for weekly scheduled visits twice in January. HCO: We doubled participation from payors, with more o...","published_at":"2026-02-16T20:36:02Z","canonical_url":"https://wefunder.com/feed/260000"},{"id":243722,"entity_id":"wefunder:feed_item:243722","title":"2025: A Year of Growth, Gratitude, and Groundwork","preview":"Happy 2026 Everyone,As a new year begins, I want to take a moment to reflect on what we've built together in 2025 and to thank you for being part of it.Last year, we raised $2.84M in our seed round, including $1.1M from 545 investors in the Wefunder community. That momentum helped us accelerate critical milestones across every part of the business. Safar Partners immediately followed on with a further $1M on less dilutive terms as well, bringing our total equity raised to $3.84M,\u0026nbsp;the mos...","published_at":"2026-01-14T21:49:49Z","canonical_url":"https://wefunder.com/feed/243722"},{"id":228455,"entity_id":"wefunder:feed_item:228455","title":"HCO Investor Update – November 2025","preview":"Dear Investors,November has been a strong month across the board with continued momentum at HCO and a breakout month for Imago. We officially closed and disbursed capital raised through our Community Round on Wefunder, and final documentation for the Imago acquisition is also in the final stages. 🔥 Imago Hits Major MilestonesNovember was Imago’s second-best month on record, with revenue above target for Month 1 post-acquisition. Board Continuity: Our board observers from Desert Angels and Cyb...","published_at":"2025-12-07T18:33:34Z","canonical_url":"https://wefunder.com/feed/228455"},{"id":193576,"entity_id":"wefunder:feed_item:193576","title":"We Did It – $1.1M Raised. Thank You. 💙","preview":"Our community round is officially closed — and thanks to you, we’ve raised over $1.1 million from 545 investors, bringing our seed round to $3.84M raised overall! 🎉We were also featured in Kingsrowd’s weekly funding report as the #19 MOST FUNDED Reg CF campaign last week - putting us among the top 5% of all active campaigns nationwide! 🏆Every investor in our community round has invested alongside our institutional investors, including Safar Partners, Cranberry Capital, Simon School Venture Fu...","published_at":"2025-09-30T14:10:04Z","canonical_url":"https://wefunder.com/feed/193576"},{"id":193509,"entity_id":"wefunder:feed_item:193509","title":"🚨LAST CALL \u0026amp; Thank you 🚨","preview":"We’re down to the wire. It’s your final moment to invest or increase your stake in HCO.There won’t be another opportunity to invest at this early stage, and we will NOT be extending the round. This is it.\u0026nbsp;Take a look at our page: our traction is tremendous, and now we’ve really outgrown the terms of our investment round.We’ve already started executing on $9.15M in contract value and will start preparing for our next growth round at a significantly higher valuation.\u0026nbsp;We’re delivering ...","published_at":"2025-09-29T00:00:22Z","canonical_url":"https://wefunder.com/feed/193509"},{"id":193505,"entity_id":"wefunder:feed_item:193505","title":"🚨Final Hours to Invest","preview":"WOW. It’s incredible to see investors rally around HCO this weekend. Reiterating what I've said via personal email to everyone who’s invested or increased their investment at the last moment: THANK YOUWe’re nearing the finish line, but there’s still time to join us before the doors close in just a few hours.HCO is tackling one of the world’s most urgent health challenges: respiratory attacks, which impact 690M people globally.\u0026nbsp;Our agentic, multimodal AI is trained on real-time deep organ...","published_at":"2025-09-28T18:51:23Z","canonical_url":"https://wefunder.com/feed/193505"},{"id":193502,"entity_id":"wefunder:feed_item:193502","title":"⌛Last Chance to Invest: Community Round Closes TODAY!","preview":"This is it! It’s the last day of our first-ever community round, and your absolute last chance to get in on this deal.\u0026nbsp;But, if you know us, you know we're always moving forward, so this is not just a typical \"closing soon\" announcement. Our latest win: we've been approved as a partner to a premier benefits broker focused on the employer market! Contracting is underway now.That's just the latest milestone in a series of milestones that show our focus on execution. Since opening the round,...","published_at":"2025-09-28T14:00:34Z","canonical_url":"https://wefunder.com/feed/193502"}],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-15T04:17:53Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-14T23:53:33Z","as_of":"2026-06-15T04:17:53Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-14T23:53:33Z","as_of":"2026-06-15T04:17:53Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-02-21T20:08:13Z","as_of":"2026-06-15T04:17:53Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-02-21T20:08:13Z","as_of":"2026-06-15T04:17:53Z","confidence":"medium"}}}}}}